8-K
Current Report
Avalo Therapeutics, Inc. Filed Acc 0001104659-26-056482
Material agreement · Results of operations · Regulation FD disclosure
- Item 1.01 Entry into a material definitive agreement
- Item 2.02 Results of operations and financial condition
- Item 7.01 Regulation FD disclosure
From the SEC's structured data for this filing
Loading tm2613717d1_8k.htm…